A preliminary study suggests that Black people who have autoimmune neurologic diseases, multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), may respond differently than white people to a common therapy ...
Apr 14, 2021
1
4
Over 1 billion people globally are affected by iron-deficiency anemia. In sub-Saharan Africa, anemia is a major public health concern with roughly 60% of the population suffering from anemia. Around half of those cases are ...
Nov 25, 2020
0
7
COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. ...
Nov 11, 2020
0
1
A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the ...
Oct 16, 2020
0
45
Many diseases require intravenous (IV) infusion therapy. But uncontrolled infusion rates and incorrect dosing can lead to severe complications or even death. The ECGF-IS project aims to improve the safety of IV therapies ...
Sep 1, 2020
0
2
(HealthDay)—Insulin infusion helps achieve glycemic targets and may reduce the risk for poor outcomes in patients with hyperglycemia and COVID-19, according to a study published online May 19 in Diabetes Care.
May 29, 2020
0
2
Eight of the top 10 selling drugs in the United States are biologics, which are produced from living organisms or certain components of living organisms. Subcutaneous injection—where the drug is injected into the tissue ...
Jan 15, 2020
0
0
An article in the current issue of Psychotherapy and Psychosomatics explores the psychological aspects of pain management with particular reference to placebo infusions in back pain.
Oct 8, 2019
0
5
(HealthDay)—The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, ...
Jul 18, 2019
0
2
(HealthDay)—Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years ...
Jun 4, 2019
0
2
